Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

348282

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Muscular Dystrophy: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions he has had with his counterparts in the devolved assemblies on (a) future decisions on the availability and (b) consistency of provision by area of drugs and treatment for Duchenne muscular dystrophy.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	938
answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>No meetings have taken place between the Ministers of the Department and their counterparts in the devolved Assemblies to discuss drugs and treatments for Duchenne muscular dystrophy.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/06/2015 14:40:22 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon

348372

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Southend University Hospital: Accident and Emergency Departments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent (a) discussions he has held and (b) representations he has received concerning Southend University Hospital NHS Foundation Trust's performance on A&E waiting times; and if he will make a statement.
tabling member constituency	Southend West
tabling member printed	Sir David Amess
uin	1096
answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>A search by the Department’s Ministerial private offices and of the Ministerial correspondence database shows no discussions have been held, nor representations received in the past six months about Southend University Hospital NHS Foundation Trust's performance on accident and emergency waiting times.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/06/2015 14:26:45 answering member 3918 label Biography information for Jane Ellison
tabling member	44 label Biography information for Sir David Amess

348396

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what proportion of cancer patients received (a) intensity modulated and (b) stereotactic radiotherapy in the latest month for which figures are available.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	952
answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>NHS England monitors the progress in achieving the following standard:</p><p> </p><p> </p><p> </p><p>- A minimum 24% of patients requiring radical radiotherapy have access to inverse planned Intensity Modulated Radiotherapy (IMRT).</p><p> </p><p> </p><p> </p><p>NHS England monitors this standard as a three month rolling average. The latest data shows that 6,397 patients received IMRT during the period from December 2014 to February 2015, a proportion of 37% of patients requiring radical radiotherapy.</p><p> </p><p> </p><p> </p><p>NHS England does not hold data centrally relating to the proportion of cancer patients receiving stereotactic radiotherapy.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/06/2015 14:33:38 answering member 3918 label Biography information for Jane Ellison
tabling member	1506 label Biography information for Andrew Gwynne

348412

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medical Equipment: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether NHS England plans to establish reference prices for medical devices beyond those named in the Commissioning Intentions for 2015-16.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	1018
answer	answer is ministerial correction date of answer 10/06/2015 answer text <p>The commissioning intentions state NHS England will look at excluded devices and some drugs. The process began with implantable cardiac devices, bone anchored hearing devices and transcatheter aortic valve implantation, and proceeded to cover all excluded devices.</p><p> </p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 10/06/2015 15:53:16 answering member 3988 label Biography information for Ben Gummer
tabling member	1506 label Biography information for Andrew Gwynne

347900

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services: Staffordshire
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, in the light of the Staffordshire Distressed Health Economy report by KPMG, what is their assessment of the ability of the Clinical Commissioning Groups to manage the risks posed by outsourcing to the cancer and end-of-life programme in Staffordshire for a 10-year period.
tabling member printed	Lord Hunt of Kings Heath
uin	HL186
answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>NHS England advises that the Transforming Cancer and End of Life Programme in Staffordshire is a partnership between four clinical commissioning groups (CCGs), two local authorities, NHS England and Macmillan Cancer Support. Resources and expertise have been provided over and above current CCG resource by Macmillan Cancer Support to mitigate any risks to delivery from capacity and capability gaps.</p><p> </p><p> </p><p> </p><p>Staffordshire CCGs did not stipulate that private sector providers should be part of the successful consortium.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL187 question first answered 09/06/2015 13:32:12 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

347901

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services: Staffordshire
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether the Staffordshire Clinical Commissioning Groups stipulated that private-sector providers should be part of the successful consortium in order to manage the risk posed by outsourcing to the cancer and end-of-life programme in Staffordshire for a 10-year period; and if so, why.
tabling member printed	Lord Hunt of Kings Heath
uin	HL187
answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>NHS England advises that the Transforming Cancer and End of Life Programme in Staffordshire is a partnership between four clinical commissioning groups (CCGs), two local authorities, NHS England and Macmillan Cancer Support. Resources and expertise have been provided over and above current CCG resource by Macmillan Cancer Support to mitigate any risks to delivery from capacity and capability gaps.</p><p> </p><p> </p><p> </p><p>Staffordshire CCGs did not stipulate that private sector providers should be part of the successful consortium.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL186 question first answered 09/06/2015 13:32:12 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

347902

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Nottingham University Hospitals NHS Trust: Dermatology
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what is their assessment of the independent investigation into the loss of dermatology specialist services at the Nottingham University Hospitals NHS Trust.
tabling member printed	Lord Hunt of Kings Heath
uin	HL188
answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>The independent service review of dermatology services in Nottingham was initiated by Rushcliffe Clinical Commissioning Group (CCG), as the co-ordinating commissioner for Circle Nottingham services on behalf of the four Nottinghamshire CCGs.</p><p> </p><p> </p><p> </p><p>The review reported on 4 June 2015, finding that no one person or organisation is to blame for the current problems faced by dermatology services in Nottingham. The review panel made recommendations for joint action by Rushcliffe CCG, Circle and Nottingham University Hospital NHS Trust to address the immediate local situation. It also made a national recommendation for consideration by Health Education England.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL189 question first answered 09/06/2015 13:33:00 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

347903

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Nottingham University Hospitals NHS Trust: Dermatology
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what steps they are taking to hold Rushcliffe Clinical Commissioning Group to account for the failures in the commissioning of dermatology specialist services at the Nottingham University Hospital NHS Trust, described in a report of the independent investigation as an "unmitigated disaster".
tabling member printed	Lord Hunt of Kings Heath
uin	HL189
answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>The independent service review of dermatology services in Nottingham was initiated by Rushcliffe Clinical Commissioning Group (CCG), as the co-ordinating commissioner for Circle Nottingham services on behalf of the four Nottinghamshire CCGs.</p><p> </p><p> </p><p> </p><p>The review reported on 4 June 2015, finding that no one person or organisation is to blame for the current problems faced by dermatology services in Nottingham. The review panel made recommendations for joint action by Rushcliffe CCG, Circle and Nottingham University Hospital NHS Trust to address the immediate local situation. It also made a national recommendation for consideration by Health Education England.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL188 question first answered 09/06/2015 13:33:01 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

347950

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Diabetes: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, in which of the seven demonstrator sites the NHS National Diabetes Prevention Programme began operating.
tabling member constituency	Leicester East
tabling member printed	Keith Vaz
uin	828
answer	answer is ministerial correction date of answer 10/06/2015 answer text <p>The diabetes prevention programme announced seven demonstrator sites on 12 March 2015:</p><p> </p><p> </p><p> </p><p>- Birmingham South and Central Clinical Commissioning Group (CCG)</p><p> </p><p>- Bradford City CCG</p><p> </p><p>- Durham County Council</p><p> </p><p>- Herefordshire CCG/Local Authority (LA)</p><p> </p><p>- Medway CCG/LA</p><p> </p><p>- Salford CCG/LA</p><p> </p><p>- Southwark Council and CCG</p><p> </p><p> </p><p> </p><p>The demonstrator sites were specifically chosen with different levels of service provision to provide important learning in establishing the National Diabetes Prevention Programme. Six demonstrator sites have existing type 2 diabetes prevention services.</p><p> </p><p> </p><p> </p><p>The programme is currently working with the demonstrator sites to jointly develop plans to amend and scale up their services. This will inform the development of the programme.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 10/06/2015 14:22:16 answering member 3918 label Biography information for Jane Ellison
tabling member	338 label Biography information for Keith Vaz

347951

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many patients have been identified as possibly diabetic by the NHS Health Check in the last 12 months.
tabling member constituency	Leicester East
tabling member printed	Keith Vaz
uin	829
answer	answer is ministerial correction date of answer 10/06/2015 answer text <p>This information is not held centrally.</p><p> </p><p> </p><p> </p><p>Public Health England (PHE) is currently working with the health &amp; social care information centre to establish a national data standard which will allow uniformed reporting on the NHS Health Check. PHE is also exploring options for the introduction of a national for representational data collection system for the NHS health check programme.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 10/06/2015 14:59:25 answering member 3918 label Biography information for Jane Ellison
tabling member	338 label Biography information for Keith Vaz